News
Actinium Pharmaceuticals and Philogen S.p.A. Announce Collaboration for Alpha Therapy Based Antiangi
Actinium Pharmaceuticals, Inc. and Philogen S.p.A today announced that they have entered into a collaboration agreement under which the companies will explore feasibility and best...
News
PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
 PAREXEL Consulting, a business unit of PAREXEL International and a leading global consultancy serving the biopharmaceutical and medical device industries, today announced that Leanne...
News
Ampio announces successful Pre-IND meeting with the Ophthalmology Division of the FDA on Optinaa
Ampio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing drugs for the treatment of inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male...
News
Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in
Biodel Inc.announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the...
News
Pancreatic Cancer Risk May Be Reduced By High Dietary Antioxidant Intake
Individuals can significantly reduce their risk of developing pancreatic cancer by increasing their dietary intake of the antioxidant vitamins C, E, and selenium, say researchers...
News
FDA Approves First Drug To Reduce Risk Of HIV Infection
The US Food and Drug Administration (FDA), announced on Monday that it has approved a existing drug, Truvada for reducing risk of infection by sexually...
News
For Patients With Acute Myeloid Leukemia, Mutation In Gene IDH A Possible Target For Treatment
Many patients with acute myeloid leukemia (AML) share a mutation in a gene called IDH. A University of Colorado Cancer Center study published this week...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
